| Dr Johannah Lindsey Dickens Hay, MD | |
|
120 South Story Street, Boone, IA 50036-4739 | |
| (515) 432-4444 | |
| (515) 432-1331 |
| Full Name | Dr Johannah Lindsey Dickens Hay |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 120 South Story Street, Boone, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508157033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD60396539 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boone County Hospital | Boone, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boone County Family Medicine Tr | 0941192751 | 9 |
News Archive
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The latest Medicare Supplement membership figures show continued growth in the number of new policies being issued, according to Mark Farrah Associates. The number of policies issued in the last three years increased by 1.25% in 2009 when compared to the 2008 base. Growth slacked off somewhat compared to 2008 when carriers had experienced 2.67% growth in new policies. Nonetheless, this is encouraging as Medigap carriers are positioning to introduce new Plans M and N on June 1, 2010.
Experts at a prestigious medical conference hosted by the American Geriatrics Society and funded by the National Institutes of Health's National Institute on Aging hope their work-reported this week in the Journal of the American Geriatrics Society-can help yield hard evidence to address the range of "soft tissue" and bone disorders that contribute to falls, fractures, and muscle loss as we age.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
A new study from the Centre for Addiction and Mental Health has found evidence that a specific gene is linked to suicidal behaviour, adding to our knowledge of the many complex causes of suicide. This research may help doctors one day target the gene in prevention efforts.
› Verified 6 days ago
| Entity Name | Boone County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467434225 PECOS PAC ID: 7416840335 Enrollment ID: O20040204001048 |
News Archive
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The latest Medicare Supplement membership figures show continued growth in the number of new policies being issued, according to Mark Farrah Associates. The number of policies issued in the last three years increased by 1.25% in 2009 when compared to the 2008 base. Growth slacked off somewhat compared to 2008 when carriers had experienced 2.67% growth in new policies. Nonetheless, this is encouraging as Medigap carriers are positioning to introduce new Plans M and N on June 1, 2010.
Experts at a prestigious medical conference hosted by the American Geriatrics Society and funded by the National Institutes of Health's National Institute on Aging hope their work-reported this week in the Journal of the American Geriatrics Society-can help yield hard evidence to address the range of "soft tissue" and bone disorders that contribute to falls, fractures, and muscle loss as we age.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
A new study from the Centre for Addiction and Mental Health has found evidence that a specific gene is linked to suicidal behaviour, adding to our knowledge of the many complex causes of suicide. This research may help doctors one day target the gene in prevention efforts.
› Verified 6 days ago
| Entity Name | Boone County Family Medicine Tr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033154836 PECOS PAC ID: 0941192751 Enrollment ID: O20040326000708 |
News Archive
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The latest Medicare Supplement membership figures show continued growth in the number of new policies being issued, according to Mark Farrah Associates. The number of policies issued in the last three years increased by 1.25% in 2009 when compared to the 2008 base. Growth slacked off somewhat compared to 2008 when carriers had experienced 2.67% growth in new policies. Nonetheless, this is encouraging as Medigap carriers are positioning to introduce new Plans M and N on June 1, 2010.
Experts at a prestigious medical conference hosted by the American Geriatrics Society and funded by the National Institutes of Health's National Institute on Aging hope their work-reported this week in the Journal of the American Geriatrics Society-can help yield hard evidence to address the range of "soft tissue" and bone disorders that contribute to falls, fractures, and muscle loss as we age.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
A new study from the Centre for Addiction and Mental Health has found evidence that a specific gene is linked to suicidal behaviour, adding to our knowledge of the many complex causes of suicide. This research may help doctors one day target the gene in prevention efforts.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Johannah Lindsey Dickens Hay, MD 120 South Story Street, Boone, IA 50036-4739 Ph: (515) 432-4444 | Dr Johannah Lindsey Dickens Hay, MD 120 South Story Street, Boone, IA 50036-4739 Ph: (515) 432-4444 |
News Archive
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The latest Medicare Supplement membership figures show continued growth in the number of new policies being issued, according to Mark Farrah Associates. The number of policies issued in the last three years increased by 1.25% in 2009 when compared to the 2008 base. Growth slacked off somewhat compared to 2008 when carriers had experienced 2.67% growth in new policies. Nonetheless, this is encouraging as Medigap carriers are positioning to introduce new Plans M and N on June 1, 2010.
Experts at a prestigious medical conference hosted by the American Geriatrics Society and funded by the National Institutes of Health's National Institute on Aging hope their work-reported this week in the Journal of the American Geriatrics Society-can help yield hard evidence to address the range of "soft tissue" and bone disorders that contribute to falls, fractures, and muscle loss as we age.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
A new study from the Centre for Addiction and Mental Health has found evidence that a specific gene is linked to suicidal behaviour, adding to our knowledge of the many complex causes of suicide. This research may help doctors one day target the gene in prevention efforts.
› Verified 6 days ago
Trishia A Filipiak, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 S Story St, Boone, IA 50036 Phone: 515-432-4444 | |
Sascha Parsons, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 S Story St, Boone, IA 50036 Phone: 515-432-4444 Fax: 515-432-1331 | |
Mr. Frank Downs, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1115 South Marshall Street, Boone County Family Medicine, Boone, IA 50036 Phone: 515-432-2335 Fax: 515-432-2357 | |
Molly Eloise Gentle, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1015 Union St, Boone, IA 50036 Phone: 515-432-3140 | |
Dr. Joshua James Anderson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 S Marshall St, Boone, IA 50036 Phone: 515-432-2335 Fax: 515-432-2357 | |
Dr. Jason Ray Sheffler, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1115 S Marshall St, Boone, IA 50036 Phone: 515-432-2335 Fax: 515-432-2357 |